This report results from a study of the uses, present and potential, of radioisotopes and nuclear techniques in the pharmaceutical and allied industries. It deals primarily with the technical feasibility of radioisotopic methods as applied to problems associated with pharmaceutical research, production, packaging and control.nThe development of radioisotopes as tools for science and industry during the past 15 years has made possible a significant expansion of scientific methodology and technological development in American industry. Estimates of direct savings to industry through the use of radioisotopic methods range to 500 millions of dollars currently, with the expectation that this figure will be measured in billions within the current decade.
展开▼
